Latest News about NVO
Recent news which mentions NVO
What's Going On With Eli Lilly And Company Shares Wednesday?
August 07, 2024
From Benzinga
Weight-Loss Giant Novo Nordisk Tumbles To 200-Day Average Support: 'Weakness Could Be Buying Opportunity,' Analyst Says
August 07, 2024
Tickers
NVO
From Benzinga
Ozempic-Maker Novo Nordisk Reveals Patients Stay On Wegovy Weight-Loss Drug For 6 Months Due To Low Availability
August 07, 2024
From Benzinga
Tickers
NVO
From InvestorPlace
Is It Too Late to Buy Novo Nordisk Stock After Its 57% Surge?
August 07, 2024
From Motley Fool
Novo Nordisk Tumbles 3% In Wednesday Premarket: What's Causing 'Miracle' Weight Loss Drug Ozempic Maker's Stock Slide?
August 07, 2024
From Benzinga
From Benzinga
After Ozempic And Botox, Hollywood Is Going Gaga Over This New Anti-Aging Supplement
August 05, 2024
From Benzinga
3 Unstoppable Stocks to Buy in August
August 03, 2024
From Motley Fool
Eli Lilly vs Novo Nordisk: A Recent Study Suggests This Company Has the Best Weight Loss Drug
August 03, 2024
From Motley Fool
Using Weight Loss Medications Such As Wegovy, Zepbound? Psychologist Warns Of Linked Eating Disorder Risks
August 02, 2024
From Benzinga
From Benzinga
Hims & Hers Stock Is Looking to Cash in From the GLP-1 Hype, but Will Its Controversial Strategy Pay Off?
August 02, 2024
From Motley Fool
From Motley Fool
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
August 02, 2024
From Motley Fool
Why Eli Lilly Stock Trounced the Market on Thursday
August 01, 2024
From Motley Fool
What Are the Hottest Weight Loss Stocks Right Now? 3 Top Picks.
August 01, 2024
From InvestorPlace
Pfizer Just Confirmed It's a Dividend Investor's Dream Stock
August 01, 2024
From Motley Fool
From Motley Fool
The Top 7 Stocks to Buy Now: Summer 2024
July 31, 2024
From InvestorPlace
From Benzinga
From Benzinga
Novo Nordisk's Ozempic Reduces Smoking-Related Health Interventions In Diabetic Patients, Study Finds
July 30, 2024
From Benzinga
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
July 30, 2024
From Motley Fool
3 Overlooked Stocks Poised for a Breakout Very Soon
July 29, 2024
From InvestorPlace
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.